In contrast, implanted MCF-7 CEMIP shBiP or MCF-7 CEMIP BiP-/- cells formed tumors that grew for the first 2 weeks, followed by tumor regression by week 4 (Figure 5, Supplementary Figure 7). Here, HSPA5 is linked to neoplasm.